Monday, February 06, 2012

Lawmakers Probe Drugmakers on Generic ADD Drug Shortages

Several Democratic lawmakers are requesting information from two brand drugmakers and the Drug Enforcement Administration (DEA) on production quotas that may limit generic attention deficit disorder (ADD) drugs. The four leading House members accuse Shire Pharmaceuticals and Novartis of “manipulating the market” by using DEA quotas that limit the amount of a particular product to flood pharmacies with more brand than generic versions of ADD drugs.
Generic Line

Posted via email from Jack's posterous

No comments: